Ftse Mib
35.307,96
0,57%
DAX
20.351,27
0,17%
S&P 500
5.918,25
0,00%
NASDAQ
19.478,88
0,00%
Bitcoin
92.145,68
-3,06%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Annovis Bio Inc (ANVS) Annovis Bio Inc (ANVS) Notizie

ANVS

Annovis Bio (ANVS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ANVS
DataOraFonteTitoloSimboloCompagnia
11/12/202422:25Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
05/12/202414:30GlobeNewswire Inc.Annovis CEO Showcases Groundbreaking Advances in Neurodegenerative Disease Treatment on Today’s MarketplaceNYSE:ANVSAnnovis Bio Inc
08/11/202423:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
31/10/202413:00GlobeNewswire Inc.IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis BioNYSE:ANVSAnnovis Bio Inc
03/10/202414:45InvestorsHub NewsWireBeyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and MoreNYSE:ANVSAnnovis Bio Inc
02/10/202415:00InvestorsHub NewsWireTransforming Alzheimer's Treatment: Innovative Combinations to Boost CognitionNYSE:ANVSAnnovis Bio Inc
05/08/202414:00GlobeNewswire Inc.IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Annovis Bio CEO Dr. Maria Maccecchini, Live from AAIC 2024NYSE:ANVSAnnovis Bio Inc
08/07/202412:37IH Market NewsParamount-Skydance $28B Merger, Boeing Agrees to Plead Guilty with $243.6M Fine, and More NewsNYSE:ANVSAnnovis Bio Inc
21/05/202413:30GlobeNewswire Inc.Annovis Announces New Publication in a Peer-Reviewed JournalNYSE:ANVSAnnovis Bio Inc
13/05/202413:30GlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial ResultsNYSE:ANVSAnnovis Bio Inc
09/05/202413:30GlobeNewswire Inc.Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s DiseaseNYSE:ANVSAnnovis Bio Inc
06/05/202423:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:ANVSAnnovis Bio Inc
06/05/202413:30GlobeNewswire Inc.Annovis Bio CEO Maria Maccecchini Issues Letter to StockholdersNYSE:ANVSAnnovis Bio Inc
29/04/202416:10GlobeNewswire Inc.Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s DiseaseNYSE:ANVSAnnovis Bio Inc
02/04/202413:30GlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial ResultsNYSE:ANVSAnnovis Bio Inc
28/02/202413:08IH Market NewsUS Stock Movers Before Market: Beyond Meat, eBay, First Solar, Urban Outfitters…NYSE:ANVSAnnovis Bio Inc
12/02/202420:00Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NYSE:ANVSAnnovis Bio Inc
01/02/202422:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NYSE:ANVSAnnovis Bio Inc
22/11/202322:27Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:ANVSAnnovis Bio Inc
21/11/202320:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ANVSAnnovis Bio Inc
02/11/202312:30Business WireAnnovis Bio Measures Novel Biomarkers in Plasma of Parkinson’s PatientsNYSE:ANVSAnnovis Bio Inc
01/11/202317:24Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ANVSAnnovis Bio Inc
31/10/202313:00Business WireAnnovis Bio Announces Pricing of $7.5 Million Public OfferingNYSE:ANVSAnnovis Bio Inc
30/10/202321:48Business WireAnnovis Bio Announces Launch of Proposed Public OfferingNYSE:ANVSAnnovis Bio Inc
30/10/202321:42Business WireAnnovis Bio Receives Positive Recommendation to Continue Phase 2/3 Trial of Buntanetap for Alzheimer’s Disease Patients From the Independent Data and Safety Monitoring Board (DSMB)NYSE:ANVSAnnovis Bio Inc
24/10/202315:13Business WireAnnovis Bio Showcases Promising Progress in Novel Drug Development at the 2023 Clinical Trials on Alzheimer's Disease ConferenceNYSE:ANVSAnnovis Bio Inc
21/09/202315:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNYSE:ANVSAnnovis Bio Inc
15/08/202313:20Business WireAnnovis Bio Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateNYSE:ANVSAnnovis Bio Inc
18/07/202314:18Business WireContinued Positive Performance of Novel Drug Development by Annovis Bio Presented at 2023 Alzheimer's Association International ConferenceNYSE:ANVSAnnovis Bio Inc
27/06/202313:30Business WireAnnovis Bio Announces the Filing of a Groundbreaking PatentNYSE:ANVSAnnovis Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:ANVS

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
PRY
Prysmian
BIT
BAMI
Banco BPM
BIT
TRN
Terna Trasmissione Elett...
BIT
LDO
Leonardo
BIT
LTMC
Lottomatica
BIT
RACE
Ferrari NV
BIT
MONC
Moncler
BIT
SPM
Saipem
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network